Jihoon Kim

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 352 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Prognostic Implications of Door‐to‐Balloon Time and Onset‐to‐Door Time on Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Jonghanne Park, Ki Hong Choi, Joo Myung Lee et al. · Journal of the American Heart Association · 2019 · 205 citations · Full text

Further Shortening, Timely Reperfusion Therapy, Prognostic Implications +16

Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease

Joo Myung Lee, Ki Hong Choi, Bon‐Kwon Koo et al. · Journal of the American College of Cardiology · 2019 · 176 citations · Full text

Cardiovascular Disease, Atherosclerosis, Plaque Characteristics +9

Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock

Joo Myung Lee, Tae‐Min Rhee, Joo‐Yong Hahn et al. · Journal of the American College of Cardiology · 2018 · 116 citations

Percutaneous Coronary Intervention, Cardiogenic Shock, Cardiovascular Disease +6

Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study

Jihoon Kim, Danbee Kang, Hye‐Jeong Park et al. · European Heart Journal · 2020 · 84 citations · Full text